The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment
Open accessAbstract
We report the discovery and characterization of SM-406 (compound 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs). This compound binds to XIAP, cIAP1, and cIAP2 proteins with K(i) of 66.4, 1.9, and 5.1 nM, respectively. Compound 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degradation of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines. It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth. Compound 2 is currently in phase I clinical trials for the treatment of human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Improved protein–ligand docking using GOLD
Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10465 · Cited by 3,067
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756
TNF-α Induces Two Distinct Caspase-8 Activation Pathways
Wang, L., Du, F., & Wang, X. (2008) · Cell · doi:10.1016/j.cell.2008.03.036 · Cited by 1,351
Rothe, M., Pan, M.-G., Henzel, W. J., Ayres, T. M., & V. Goeddel, D. (1995) · Cell · doi:10.1016/0092-8674(95)90149-3 · Cited by 1,253
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218
Bertrand, M. J. M., Milutinovic, S., Dickson, K. M., Ho, W. C., Boudreault, A., Durkin, J., Gillard, J. W., Jaquith, J. B., Morris, S. J., & Barker, P. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.014 · Cited by 1,109
IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis
Vince, J. E., Wong, W. W.-L., Khan, N., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.037 · Cited by 1,053
Srinivasula, S. M., Hegde, R., Saleh, A., Datta, P., Shiozaki, E., Chai, J., Lee, R.-A., Robbins, P. D., Fernandes-Alnemri, T., Shi, Y., et al. (2001) · Nature · doi:10.1038/35065125 · Cited by 1,013
Structural and biochemical basis of apoptotic activation by Smac/DIABLO
Chai, J., Du, C., Wu, J.-W., Kyin, S., Wang, X., & Shi, Y. (2000) · Nature · doi:10.1038/35022514 · Cited by 864
Structural Basis for the Inhibition of Caspase-3 by XIAP
Riedl, S. J., Renatus, M., Schwarzenbacher, R., Zhou, Q., Sun, C., Fesik, S. W., Liddington, R. C., & Salvesen, G. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00274-4 · Cited by 792
IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
Gyrd-Hansen, M., & Meier, P. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2889 · Cited by 790
Mechanism of XIAP-Mediated Inhibition of Caspase-9
Shiozaki, E. N., Chai, J., Rigotti, D. J., Riedl, S. J., Li, P., Srinivasula, S. M., Alnemri, E. S., Fairman, R., & Shi, Y. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00054-6 · Cited by 719
From bench to clinic with apoptosis-based therapeutic agents
Nicholson, D. W. (2000) · Nature · doi:10.1038/35037747 · Cited by 687
Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain
Liu, Z., Sun, C., Olejniczak, E. T., Meadows, R. P., Betz, S. F., Oost, T., Herrmann, J., Wu, J. C., & Fesik, S. W. (2000) · Nature · doi:10.1038/35050006 · Cited by 646
Structural Basis of Caspase-7 Inhibition by XIAP
Chai, J., Shiozaki, E., Srinivasula, S. M., Wu, Q., Dataa, P., Alnemri, E. S., & Shi, Y. (2001) · Cell · doi:10.1016/s0092-8674(01)00272-0 · Cited by 581
The inhibitors of apoptosis (IAPs) as cancer targets
Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565
Nikolovska-Coleska, Z., Wang, R., Fang, X., Pan, H., Tomita, Y., Li, P., Roller, P. P., Krajewski, K., Saito, N. G., Stuckey, J. A., et al. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.05.055 · Cited by 548
Self-citationIAP-targeted therapies for cancer
LaCasse, E. C., Mahoney, D. J., Cheung, H. H., Plenchette, S., Baird, S., & Korneluk, R. G. (2008) · Oncogene · doi:10.1038/onc.2008.302 · Cited by 524
Structural Basis of Caspase Inhibition by XIAP
Huang, Y., Park, Y. C., Rich, R. L., Segal, D., Myszka, D. G., & Wu, H. (2001) · Cell · doi:10.1016/s0092-8674(01)00273-2 · Cited by 467
Srinivasula, S. M., & Ashwell, J. D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.008 · Cited by 450
Ponder, B. A. J. (2001) · Nature · doi:10.1038/35077207 · Cited by 446
XIAP: Apoptotic brake and promising therapeutic target
Holcik, M., Gibson, H., & Korneluk, R. G. (2001) · Apoptosis · doi:10.1023/a:1011379307472 · Cited by 385
Mehrotra, S., Languino, L. R., Raskett, C. M., Mercurio, A. M., Dohi, T., & Altieri, D. C. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.021 · Cited by 291
Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology
Shiozaki, E. N., & Shi, Y. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.07.003 · Cited by 235
Yang, Q.-H., & Du, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401253200 · Cited by 213
Sun, H., Nikolovska-Coleska, Z., Lu, J., Meagher, J. L., Yang, C.-Y., Qiu, S., Tomita, Y., Ueda, Y., Jiang, S., Krajewski, K., et al. (2007) · Journal of the American Chemical Society · doi:10.1021/ja074725f · Cited by 209
Self-citationThe Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer
Vucic, D., & Fairbrother, W. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0729 · Cited by 206
Lu, J., Bai, L., Sun, H., Nikolovska-Coleska, Z., McEachern, D., Qiu, S., Miller, R. S., Yi, H., Shangary, S., Sun, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2655 · Cited by 201
Self-citationDesign of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics
Sun, H., Nikolovska-Coleska, Z., Yang, C.-Y., Qian, D., Lu, J., Qiu, S., Bai, L., Peng, Y., Cai, Q., & Wang, S. (2008) · Accounts of Chemical Research · doi:10.1021/ar8000553 · Cited by 171
Self-citationSamuel, T., Welsh, K., Lober, T., Togo, S. H., Zapata, J. M., & Reed, J. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509381200 · Cited by 170
Structure-Based Design of Potent, Conformationally Constrained Smac Mimetics
Sun, H., Nikolovska-Coleska, Z., Yang, C.-Y., Xu, L., Liu, M., Tomita, Y., Pan, H., Yoshioka, Y., Krajewski, K., Roller, P. P., et al. (2004) · Journal of the American Chemical Society · doi:10.1021/ja047438+ · Cited by 159
Self-citationHuang, Y., Rich, R. L., Myszka, D. G., & Wu, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310061200 · Cited by 152
Sun, H., Nikolovska‐Coleska, Z., Yang, C., Xu, L., Tomita, Y. A., Krajewski, K., Roller, P. P., & Wang, S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0499108 · Cited by 134
Self-citationSrinivasula, S. M., Hegde, R. P., Saleh, A., Datta, P., Shiozaki, E. N., Chai, J., Lee, R., Robbins, P. D., Fernandes‐Alnemri, T., Shi, Y., et al. (2001) · Nature · doi:10.1038/35082622 · Cited by 115
Sun, H., Nikolovska‐Coleska, Z., Lü, J., Qiu, S., Yang, C., Gao, W., Meagher, J. L., Stuckey, J. A., & Wang, S. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm061108d · Cited by 100
Self-citationIAP antagonists: promising candidates for cancer therapy
Mannhold, R., Fulda, S., & Carosati, E. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.003 · Cited by 98
Sun, H., Stuckey, J. A., Nikolovska‐Coleska, Z., Qin, D., Meagher, J. L., Qiu, S., Lü, J., Yang, C., Saito, N. G., & Wang, S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006849 · Cited by 84
Self-citationDesign of Small-Molecule Smac Mimetics as IAP Antagonists
Wang, S. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_111 · Cited by 76
Self-citationImportance of Ligand Reorganization Free Energy in Protein−Ligand Binding-Affinity Prediction
Yang, C., Sun, H., Chen, J., Nikolovska‐Coleska, Z., & Wang, S. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9039373 · Cited by 66
Self-citationPeng, Y., Sun, H., Nikolovska‐Coleska, Z., Qiu, S., Yang, C., Lü, J., Cai, Q., Han, Y., Kang, S., Yang, D., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801254r · Cited by 55
Self-citationNonpeptidic and Potent Small-Molecule Inhibitors of cIAP-1/2 and XIAP Proteins
Sun, H., Lü, J., Liu, L., Han, Y., Qiu, S., Yang, C., Deschamps, J. R., & Wang, S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100487z · Cited by 44
Self-citationSun, W. D., Nikolovska‐Coleska, Z., Qin, D., Sun, H., Yang, C., Bai, L., Qiu, S., Wang, Y., Ma, D., & Wang, S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801101z · Cited by 39
Self-citationZhang, B., Nikolovska‐Coleska, Z., Zhang, Y., Bai, L., Qiu, S., Yang, C., Sun, H., Wang, S., & Wu, Y. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801146d · Cited by 37
Self-citationRostovtsev, V. V., Green, L. G., Fokin, V. V., & Sharpless, K. B. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020715)41:14<2596::aid-anie2596>3.0.co;2-4
Cited by
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Arkin, M. R., Tang, Y., & Wells, J. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.001 · Cited by 1,065
Recent advances in therapeutic strategies for triple-negative breast cancer
Li, Y., Zhang, H., Merkher, Y., Chen, L., Liu, N., Leonov, S., & Chen, Y. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01341-0 · Cited by 956
Targeting IAP proteins for therapeutic intervention in cancer
Fulda, S., & Vucic, D. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3627 · Cited by 837
Targeting protein–protein interactions as an anticancer strategy
Ivanov, A. A., Khuri, F. R., & Fu, H. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.007 · Cited by 401
Metadata
- Authors
- Cai, Q., Sun, H., Peng, Y., Lu, J., Nikolovska-Coleska, Z., McEachern, D., Liu, L., Qiu, S., Yang, C.-Y., Miller, R., Yi, H., Zhang, T., Sun, D., Kang, S., Guo, M., Leopold, L., Yang, D., & Wang, S.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-03-28
- Volume
- 54
- Issue
- 8
- Pages
- 2714-2726
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1203651314
- Cited by
- 272
- References
- 50
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.